RM 49
| Code | Size | Price |
|---|
| TAR-T26102-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
RM 49 is a mitomycin C derivative that has antitumor activity in vitro.
CAS:
113785-48-1
Formula:
C16H20N4O6
Molecular Weight:
364.358
Purity:
0.98
SMILES:
COc1c2N3CC4NC4C3(OC)C(COC(N)=O)c2c(O)c(N=O)c1C
References
1. Horiuchi N, Nakagawa K, Sasaki Y, Minato K, Fujiwara Y, Nezu K, Ohe Y, Saijo N. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay. Cancer Chemother Pharmacol. 1988;22(3):246-50. PubMed PMID: 2842080.